Cargando…
Host range, morphological and genomic characterisation of bacteriophages with activity against clinical Streptococcus agalactiae isolates
Streptococcus agalactiae or Group B Streptococcus (GBS) is a leading cause of sepsis in neonates. As a preventative measure prophylactic antibiotic administration is common in pregnant women colonised with GBS, but antibiotic-resistance and adverse effects on neonatal microbiomes may result. Use of...
Autores principales: | Furfaro, Lucy L., Payne, Matthew S., Chang, Barbara J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310703/ https://www.ncbi.nlm.nih.gov/pubmed/32574197 http://dx.doi.org/10.1371/journal.pone.0235002 |
Ejemplares similares
-
Genomic characterisation of perinatal Western Australian Streptococcus agalactiae isolates
por: Furfaro, Lucy L., et al.
Publicado: (2019) -
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
por: Furfaro, Lucy L., et al.
Publicado: (2018) -
Recombinant of the Staphylococcal Bacteriophage Lysin CHAP(k) and Its Elimination against Streptococcus agalactiae Biofilms
por: Shan, Yuxue, et al.
Publicado: (2020) -
Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period
por: Furfaro, Lucy L., et al.
Publicado: (2018) -
Streptococcus agalactiae
por: Faro, Sebastian
Publicado: (1993)